[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Mitomycin C Market by Manufacturers, Countries, Type and Application, Forecast to 2022

May 2017 | 116 pages | ID: N693D043247EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

SCOPE OF THE REPORT:

This report focuses on the Mitomycin C in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
  • Kyowa-kirin
  • Intas Pharmaceuticals
  • Teva
  • Bristol-Myers Squibb
  • Aspen
  • Speciality European Pharma
  • Alkem Laboratories
  • Varifarma
  • APOGEPHA
Market Segment by Countries, covering
  • United States
  • Canada
  • Mexico
Market Segment by Type, covers
  • 2 Mg
  • 10 Mg
  • 40 Mg
  • Other
Market Segment by Applications, can be divided into
  • Cancer Treatment
  • Ophthalmic Use
  • Others
There are 15 Chapters to deeply display the North America Mitomycin C market.

Chapter 1, to describe Mitomycin C Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Mitomycin C, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Mitomycin C, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Mitomycin C market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Mitomycin C Research Findings and Conclusion, Appendix, methodology and data source
1 MARKET OVERVIEW

1.1 Mitomycin C Introduction
1.2 Market Analysis by Type
  1.2.1 2 Mg
  1.2.2 10 Mg
  1.2.3 40 Mg
  1.2.4 Other
1.3 Market Analysis by Applications
  1.3.1 Cancer Treatment
  1.3.2 Ophthalmic Use
  1.3.3 Others
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Kyowa-kirin
  2.1.1 Profile
  2.1.2 Mitomycin C Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Kyowa-kirin Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Kyowa-kirin News
2.2 Intas Pharmaceuticals
  2.2.1 Profile
  2.2.2 Mitomycin C Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Intas Pharmaceuticals Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Intas Pharmaceuticals News
2.3 Teva
  2.3.1 Profile
  2.3.2 Mitomycin C Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Teva Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Teva News
2.4 Bristol-Myers Squibb
  2.4.1 Profile
  2.4.2 Mitomycin C Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Bristol-Myers Squibb Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Bristol-Myers Squibb News
2.5 Aspen
  2.5.1 Profile
  2.5.2 Mitomycin C Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Aspen Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Aspen News
2.6 Speciality European Pharma
  2.6.1 Profile
  2.6.2 Mitomycin C Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Speciality European Pharma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Speciality European Pharma News
2.7 Alkem Laboratories
  2.7.1 Profile
  2.7.2 Mitomycin C Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Alkem Laboratories Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Alkem Laboratories News
2.8 Varifarma
  2.8.1 Profile
  2.8.2 Mitomycin C Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Varifarma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Varifarma News
2.9 APOGEPHA
  2.9.1 Profile
  2.9.2 Mitomycin C Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 APOGEPHA Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 APOGEPHA News

3 NORTH AMERICA MITOMYCIN C MARKET COMPETITION, BY MANUFACTURER

3.1 North America Mitomycin C Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Mitomycin C Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Mitomycin C Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Mitomycin C Manufacturer Market Share
  3.4.2 Top 5 Mitomycin C Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA MITOMYCIN C MARKET ANALYSIS BY COUNTRIES

4.1 North America Mitomycin C Sales Market Share by Countries
4.2 North America Mitomycin C Sales by Countries (2012-2017)
4.3 North America Mitomycin C Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION MITOMYCIN C BY TYPE

5.1 North America Mitomycin C Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Mitomycin C Sales and Market Share by Type (2012-2017)
  5.1.2 North America Mitomycin C Revenue and Market Share by Type (2012-2017)
5.2 2 Mg Sales Growth and Price
  5.2.1 North America 2 Mg Sales Growth (2012-2017)
  5.2.2 North America 2 Mg Price (2012-2017)
5.3 10 Mg Sales Growth and Price
  5.3.1 North America 10 Mg Sales Growth (2012-2017)
  5.3.2 North America 10 Mg Price (2012-2017)
5.4 40 Mg Sales Growth and Price
  5.4.1 North America 40 Mg Sales Growth (2012-2017)
  5.4.2 North America 40 Mg Price (2012-2017)
5.5 Other Sales Growth and Price
  5.5.1 North America Other Sales Growth (2012-2017)
  5.5.2 North America Other Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION MITOMYCIN C BY APPLICATION

6.1 North America Mitomycin C Sales Market Share by Application (2012-2017)
6.2 Cancer Treatment Sales Growth (2012-2017)
6.3 Ophthalmic Use Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)

7 UNITED STATES MITOMYCIN C SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Mitomycin C Sales and Market Share by Type
7.3 United States Mitomycin C Sales by Application (2012-2017)
7.4 United States Mitomycin C Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Mitomycin C Sales and Market Share by Manufacturer
  7.4.2 United States Mitomycin C Revenue and Market Share by Manufacturer
7.5 United States Mitomycin C Export and Import (2012-2017)

8 CANADA MITOMYCIN C SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Mitomycin C Sales and Market Share by Type
8.3 Canada Mitomycin C Sales by Application (2012-2017)
8.4 Canada Mitomycin C Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Mitomycin C Sales and Market Share by Manufacturer
  8.4.2 Canada Mitomycin C Revenue and Market Share by Manufacturer
8.5 Canada Mitomycin C Export and Import (2012-2017)

9 MEXICO MITOMYCIN C SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Mitomycin C Sales and Market Share by Type
9.3 Mexico Mitomycin C Sales by Application (2012-2017)
9.4 Mexico Mitomycin C Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Mitomycin C Sales and Market Share by Manufacturer
  9.4.2 Mexico Mitomycin C Revenue and Market Share by Manufacturer
9.5 Mexico Mitomycin C Export and Import (2012-2017)

10 MITOMYCIN C MARKET FORECAST (2017-2022)

10.1 North America Mitomycin C Sales, Revenue and Growth Rate (2017-2022)
10.2 Mitomycin C Market Forecast by Countries (2017-2022)
  10.2.1 United States Mitomycin C Forecast (2017-2022)
  10.2.2 Canada Mitomycin C Forecast (2017-2022)
  10.2.3 Mexico Mitomycin C Forecast (2017-2022)
10.3 Mitomycin C Market Forecast by Type (2017-2022)
10.4 Mitomycin C Market Forecast by Application (2017-2022)

11 MITOMYCIN C MANUFACTURING COST ANALYSIS

11.1 Mitomycin C Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Mitomycin C

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Mitomycin C Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Mitomycin C Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
LIST OF TABLES AND FIGURES

Figure Mitomycin C Picture
Table Product Specifications of Mitomycin C
Figure North America Sales Market Share of Mitomycin C by Types in 2016
Table Types of Mitomycin C
Figure 2 Mg Picture
Table Major Manufacturers of 2 Mg
Figure 10 Mg Picture
Table Major Manufacturers of 10 Mg
Figure 40 Mg Picture
Table Major Manufacturers of 40 Mg
Figure Other Picture
Table Major Manufacturers of Other
Table North America Mitomycin C Sales Market Share by Applications in 2016
Table Applications of Mitomycin C
Figure Cancer Treatment Picture
Figure Ophthalmic Use Picture
Figure Others Picture
Figure United States Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Table Kyowa-kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa-kirin Mitomycin C Type and Applications
Table Kyowa-kirin Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Mitomycin C Type and Applications
Table Intas Pharmaceuticals Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Mitomycin C Type and Applications
Table Teva Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Mitomycin C Type and Applications
Table Bristol-Myers Squibb Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Mitomycin C Type and Applications
Table Aspen Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Speciality European Pharma Basic Information, Manufacturing Base and Competitors
Table Speciality European Pharma Mitomycin C Type and Applications
Table Speciality European Pharma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alkem Laboratories Basic Information, Manufacturing Base and Competitors
Table Alkem Laboratories Mitomycin C Type and Applications
Table Alkem Laboratories Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Varifarma Basic Information, Manufacturing Base and Competitors
Table Varifarma Mitomycin C Type and Applications
Table Varifarma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table APOGEPHA Basic Information, Manufacturing Base and Competitors
Table APOGEPHA Mitomycin C Type and Applications
Table APOGEPHA Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Mitomycin C Sales by Manufacturer (2016-2017)
Figure North America Mitomycin C Sales Market Share by Manufacturer in 2016
Figure North America Mitomycin C Sales Market Share by Manufacturer in 2017
Table North America Mitomycin C Revenue by Manufacturer (2016-2017)
Figure North America Mitomycin C Revenue Market Share by Manufacturer in 2016
Figure North America Mitomycin C Revenue Market Share by Manufacturer in 2017
Table North America Mitomycin C Price by Manufacturers (2016-2017)
Figure Top 3 Mitomycin C Manufacturer Market Share in 2016
Figure Top 3 Mitomycin C Manufacturer Market Share in 2017
Figure Top 5 Mitomycin C Manufacturer Market Share in 2016
Figure Top 5 Mitomycin C Manufacturer Market Share in 2017
Figure North America Mitomycin C Sales and Growth (2012-2017)
Table North America Mitomycin C Sales by Countries (2012-2017)
Table North America Mitomycin C Sales Market Share by Countries (2012-2017)
Figure North America 2012 Mitomycin C Sales Market Share by Countries
Figure North America 2016 Mitomycin C Sales Market Share by Countries
Figure North America Mitomycin C Revenue and Growth (2012-2017)
Table North America Mitomycin C Revenue by Countries (2012-2017)
Table North America Mitomycin C Revenue Market Share by Countries (2012-2017)
Table North America 2012 Mitomycin C Revenue Market Share by Countries
Table North America 2016 Mitomycin C Revenue Market Share by Countries
Table North America Mitomycin C Sales by Type (2012-2017)
Table North America Mitomycin C Sales Share by Type (2012-2017)
Table North America Mitomycin C Revenue by Type (2012-2017)
Table North America Mitomycin C Revenue Share by Type (2012-2017)
Figure North America 2 Mg Sales Growth (2012-2017)
Figure North America 2 Mg Price (2012-2017)
Figure North America 10 Mg Sales Growth (2012-2017)
Figure North America 10 Mg Price (2012-2017)
Figure North America 40 Mg Sales Growth (2012-2017)
Figure North America 40 Mg Price (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure North America Other Price (2012-2017)
Table North America Mitomycin C Sales by Application (2012-2017)
Table North America Mitomycin C Sales Share by Application (2012-2017)
Figure North America Cancer Treatment Sales Growth (2012-2017)
Figure North America Ophthalmic Use Sales Growth (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure United States Mitomycin C Revenue and Growth (2012-2017)
Figure United States Mitomycin C Sales and Growth (2012-2017)
Table United States Mitomycin C Sales by Type (2012-2017)
Table United States Mitomycin C Sales Market Share by Type (2012-2017)
Table United States Mitomycin C Sales by Application (2012-2017)
Table United States Mitomycin C Sales Market Share by Application (2012-2017)
Table United States Mitomycin C Sales by Manufacturer (2016-2017)
Figure United States Mitomycin C Sales Market Share by Manufacturer in 2016
Figure United States Mitomycin C Sales Market Share by Manufacturer in 2017
Table United States Mitomycin C Revenue by Manufacturer (2016-2017)
Figure United States Mitomycin C Revenue Market Share by Manufacturer in 2016
Figure United States Mitomycin C Revenue Market Share by Manufacturer in 2017
Table United States Mitomycin C Export and Import (2012-2017)
Figure Canada Mitomycin C Revenue and Growth (2012-2017)
Figure Canada Mitomycin C Sales and Growth (2012-2017)
Table Canada Mitomycin C Sales by Type (2012-2017)
Table Canada Mitomycin C Sales Market Share by Type (2012-2017)
Table Canada Mitomycin C Sales by Application (2012-2017)
Table Canada Mitomycin C Sales Market Share by Application (2012-2017)
Table Canada Mitomycin C Sales by Manufacturer (2016-2017)
Figure Canada Mitomycin C Sales Market Share by Manufacturer in 2016
Figure Canada Mitomycin C Sales Market Share by Manufacturer in 2017
Table Canada Mitomycin C Revenue by Manufacturer (2016-2017)
Figure Canada Mitomycin C Revenue Market Share by Manufacturer in 2016
Figure Canada Mitomycin C Revenue Market Share by Manufacturer in 2017
Table Canada Mitomycin C Export and Import (2012-2017)
Figure Mexico Mitomycin C Revenue and Growth (2012-2017)
Figure Mexico Mitomycin C Sales and Growth (2012-2017)
Table Mexico Mitomycin C Sales by Type (2012-2017)
Table Mexico Mitomycin C Sales Market Share by Type (2012-2017)
Table Mexico Mitomycin C Sales by Application (2012-2017)
Table Mexico Mitomycin C Sales Market Share by Application (2012-2017)
Table Mexico Mitomycin C Sales by Manufacturer (2016-2017)
Figure Mexico Mitomycin C Sales Market Share by Manufacturer in 2016
Figure Mexico Mitomycin C Sales Market Share by Manufacturer in 2017
Table Mexico Mitomycin C Revenue by Manufacturer (2016-2017)
Figure Mexico Mitomycin C Revenue Market Share by Manufacturer in 2016
Figure Mexico Mitomycin C Revenue Market Share by Manufacturer in 2017
Table Mexico Mitomycin C Export and Import (2012-2017)
Figure North America Mitomycin C Sales, Revenue and Growth Rate (2017-2022)
Table North America Mitomycin C Sales Forecast by Countries (2017-2022)
Table North America Mitomycin C Market Share Forecast by Countries (2017-2022)
Figure United States Mitomycin C Sales Forecast (2017-2022)
Figure Canada Mitomycin C Sales Forecast (2017-2022)
Figure Mexico Mitomycin C Sales Forecast (2017-2022)
Table North America Mitomycin C Sales Forecast by Type (2017-2022)
Table North America Mitomycin C Market Share Forecast by Type (2017-2022)
Table North America Mitomycin C Sales Forecast by Application (2017-2022)
Table North America Mitomycin C Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mitomycin C
Figure Manufacturing Process Analysis of Mitomycin C
Figure Mitomycin C Industrial Chain Analysis
Table Raw Materials Sources of Mitomycin C Major Manufacturers in 2016
Table Major Buyers of Mitomycin C
Table Distributors/Traders/ Dealers List


More Publications